Abstract
Photosensitizer fluorescence photobleaching and Singlet Oxygen (1O2) Luminescence Dosimetry (SOLD) are being studied as potential dosimetric tools for ALA-PDT of skin diseases. However, the correlation of both SOLD data and PpIX fluorescence to 1O2 distribution is difficult to interpret because of the temporal and spatial variations of the PDT parameters (light fluence rate, photosensitizer concentration and oxygen concentration). This work used our dynamic model to investigate both dosimetry approaches for varied PpIX concentration and distribution, and three commonly used treatment wavelengths. The results show that SOLD is much less dependent upon the treatment parameters, which implies it has better potential as a “gold standard” dosimetric tool for clinical PDT.
© 2011 OSA/SPIE
PDF ArticleMore Like This
D. Parmeswaran, P. Aruna, P.K. Gupta, and S. Ganesan
4433_128 European Conference on Biomedical Optics (ECBO) 2001
Hugo J. van Staveren, Jolanda van den Boogert, Ron W.F. de Bruin, Richard van Hillegersberg, and Peter D. Siersema
JMA7 Biomedical Topical Meeting (BIOMED) 1999
Willem M. Star
TSuA2 Therapeutic Laser Applications (BIOMED) 1998